SCR-LIP-000410 · Claim · machine-readable JSON →

In 100 women with Stage I-III lipedema, tumescent or water-assisted liposuction was followed at six months by 77% reducing or discontinuing benzodiazepines and by significant improvements in anxiety, pain (VAS), sleep, and body image, with only 8% minor complications and no major adverse events.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
1 source(s)
Dates
2026-07-19 → 2026-07-19

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-07-19

Evidence over time

2026Liposuction for Lipedema Significantly Reduces Benzodiazepine Dependence: A Prospective Cohort Study. — Bruno A, D'Antimi A. (2026) · consistent

Evidence (1)

Context (PECO)

Populationadult women with Stage I-III lipedema on stable benzodiazepine therapy
Conditionlipedema
Exposuretumescent or water-assisted liposuction
Comparatorpre- vs post-surgery (within-subject)
Outcomebenzodiazepine use, anxiety, pain, sleep, body image, complications
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log